Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing · Indiana
NPHS Indianapolis Manufacturing Facility (IMS)
Indianapolis, IN · ~52 workers · 2 years of OSHA Injury Tracking Application data.
- A
- Excellent Safety Record
- 1.0
- Avg TCR
- 3.3
- Industry avg
- 0
- Fatalities
The verdict
NPHS Indianapolis Manufacturing Facility (IMS) runs at 29% of its industry's injury rate - far safer than the typical Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing workplace, earning a grade A.
NPHS Indianapolis Manufacturing Facility (IMS): 1.0 TCR = 29% of Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS 3.3 · 2y Form 300A (see methodology below)
NPHS Indianapolis Manufacturing Facility (IMS) safety composite
NPHS Indianapolis Manufacturing Facility (IMS) scores strongest on dart rate (safer than 83% of same-industry peers) and weakest on fatalities (safer than 50%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).
70/100
Percentile-weighted across 3 of 3 measures
- Total Case Rate (TCR)
- C 0.97 per 100 workers
Safer than 70% of industry peers
- DART rate
- B 0 per 100 workers
Safer than 83% of industry peers
- Fatalities
- D 0
Safer than 50% of industry peers
Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).
TCR Δ
−1.9
2022→2023
NPHS Indianapolis Manufacturing Facility (IMS) injury rate improved
NPHS Indianapolis Manufacturing Facility (IMS)'s TCR fell 1.9 from 1.9 in 2022 to 0.0 in 2023. Peak filing year was 2022 at 1.9 TCR. In 2023, DART was 0× this establishment's average TCR (severity share of cases).
2022=1.9 · 2023=0.0
OSHA ITA Form 300A scorecard
Establishment book 325412 · Indianapolis, IN AT/BELOW-IND · SMALL
Grade A · TCR 1.0 · 29% of ind
- DART 0.0 DART
- RANK #8/24
- PHOTO GlaxoSmithKline
- BOOK 2y book
- INJ 1 inj
- SIZE ~52 FTE
Nearest TCR peer: GlaxoSmithKline (0.0 TCR gap)
Read with this employer → · Industry book → · Indiana employers → · Look up another →
NPHS Indianapolis Manufacturing Facility (IMS) in the TCR neighbourhood
Average Total Case Rate among this establishment and nearest same-industry peers
- This site
NPHS Indianapolis Manufacturing Facility (IMS)
1 TCR
- GlaxoSmithKlin
GlaxoSmithKline
1 TCR
- NMR-Beloit
NMR-Beloit
1 TCR
- Medexus Pharma
Medexus Pharma Inc.
1 TCR
- Aurologistics
Aurologistics LLC
1 TCR
What this shows NPHS Indianapolis Manufacturing Facility (IMS) averages 1.0 TCR (29% of the Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS benchmark).
NPHS Indianapolis Manufacturing Facility (IMS) TCR series: 2022=1.9 · 2023=0 · BLS 3.3
Where NPHS Indianapolis Manufacturing Facility (IMS) falls in its industry
855 Pharmaceutical preparations (e establishmentsSafer than 70% of graded establishments in this industry, whose median TCR is 1.6.
Narrower to Indiana alone (the establishments it most directly competes with for workers and contracts): ranked #8 safest of 24 Pharmaceutical preparations (e employers in Indiana.
NPHS Indianapolis Manufacturing Facility (IMS) has fewer employees than the Pharmaceutical preparations (e.g., capsu median and a lower injury rate than the industry's median TCR of 1.6. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.
Year-by-Year Safety Data
| Year | TCR | DART | Injuries | Illnesses | Fatalities |
|---|---|---|---|---|---|
| 2023 | 0.0 | 0.0 | 0 | 0 | 0 |
| 2022 | 1.9 | 1.9 | 1 | 0 | 0 |
OSHA ITA peer cross-reference
Establishment peer ledger
325412 · IN · Indianapolis
855 Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing employers nationwide with a credible TCR · 12,750 rated employers in Indiana with headcount on file · 2,074 employers in Indianapolis, IN · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.
| Rel | Establishment | Metric |
|---|---|---|
| NAICS-TCR | GlaxoSmithKline | 1.0 TCR |
| NAICS-TCR | NMR-Beloit | 1.0 TCR |
| NAICS-TCR | Medexus Pharma Inc. | 1.0 TCR |
| NAICS-TCR | Aurologistics LLC | 1.0 TCR |
| STATE-SIZE | Taconic Biosciences, Inc. Cambridge City Facility | 52 FTE |
| STATE-SIZE | 2527-Windfall, IN (Monsanto Co.) | 52 FTE |
| STATE-SIZE | LeMaster Steel Erectors Inc. - Elkhart | 52 FTE |
| STATE-SIZE | Pioneer Oil Company Inc | 52 FTE |
| CITY-NEAR | Indiana University Health, Inc | 7,874 FTE |
| CITY-NEAR | Methodist Hospital | 6,862 FTE |
| CITY-NEAR | Eli Lilly - Lilly Corp Center | 6,482 FTE |
| CITY-NEAR | Lilly Technology Center | 6,472 FTE |
| NAT-TCR | SF Main Office | 1.0 TCR |
| NAT-TCR | Maui Jim Inc. - Lahaina Office | 1.0 TCR |
| NAT-TCR | Microwave Filter Company Inc | 1.0 TCR |
| NAT-TCR | Fn2 - Finance & Risk Management | 1.0 TCR |
| NAT-SIZE | Tri Star Contractors, LLC | 52 FTE |
| NAT-SIZE | White River VT Collection | 52 FTE |
| NAT-SIZE | Lithia Nissan of Eugene | 52 FTE |
| NAT-SIZE | Davidson's Masonry Inc. | 52 FTE |
Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →
Read our methodology - how this data is sourced, computed, and verified.